Latest Capital Raises News

Caspin Resources has completed the second tranche of its $4.6 million capital raising, issuing over 28 million shares and broker options to fund its promising mineral projects. This milestone strengthens the company’s position in the competitive tin and critical minerals sector.

Green Technology Metals has appointed Altris Engineering to complete the Definitive Feasibility Study for its Seymour Lithium Project in Ontario, advancing towards a mid-2026 Final Investment Decision amid a disciplined cash strategy.

Pivotal Metals highlights its fully funded exploration programs targeting high-grade copper and gold deposits in Quebec, underpinned by a significant pit-constrained resource and strategic advantages in a tier 1 jurisdiction.

Rox Resources secures ASX waiver allowing a discounted Share Purchase Plan without shareholder approval, enabling eligible investors to buy shares at $0.35 each. This move streamlines capital raising while limiting dilution to around 2.5%.

Terra Critical Minerals Limited has had its trading suspension lifted immediately following the announcement of a proposed acquisition and an options entitlements offer, signaling a pivotal moment for the critical minerals miner.

Terra Critical Minerals has launched a non-renounceable entitlement offer of quoted options to eligible shareholders, aiming to raise $586,302 in working capital with potential for $5.3 million if all options are exercised. The offer provides shareholders speculative exposure to the company’s critical and precious metals projects across Australia and North America.

Terra Critical Minerals has inked a binding deal to acquire the True American Tungsten Project in Nevada, a high-grade, historically productive site, while launching a $600,000 entitlement offer to fund exploration amid record tungsten prices.

Conico Ltd has appointed a new external auditor and secured shareholder approval for a significant 1-for-8 share consolidation at its 2025 Annual General Meeting.

Findi Limited reported a 51% surge in revenue to $49.26 million for the half year ended 30 September 2025, driven by key acquisitions in India. However, the company posted a significant operating loss of $24.65 million amid integration costs and faces material uncertainty over its going concern status.

Papyrus Australia reported a $112k net operating cash outflow in October 2025, offset by financing activities and R&D tax incentives, maintaining a runway of over five months. Despite a non-recurring legal expense and an investment write-down, the company remains confident in its operational continuity.

BTC Health has broadened its medical product portfolio through strategic acquisitions and organic growth, reporting strong early revenue gains while cautiously navigating the uncertain timing of ECMO system adoption.

Aspermont Limited reports its 37th consecutive quarter of subscription growth, launches its Mining-IQ data platform, and secures a landmark contract with Rio Tinto, signaling a strategic shift towards data-driven intelligence.